We report a case of a 49 year old woman who developed biopsy-proven xanthomas on her hands and arms after initiation of Mycophenolate mofetil therapy for systemic lupus erythematosus (SLE) and subsequently went into remission upon cessation of the medication.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014514 | PMC |
| http://dx.doi.org/10.1002/ccr3.7056 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Mycophenolate Mofetil-Induced Lymphoproliferative Disorder in a Young Adult With Chronic Posterior Uveitis.
J Vitreoretin Dis
October 2024
Michigan State University College of Human Medicine, Grand Rapids, MI, USA.
To present a case of a young adult with bilateral chronic posterior uveitis resulting from Vogt-Koyanagi-Harada (VKH) disease treated with mycophenolate mofetil who subsequently developed vitreoretinal lymphoma in the right eye. A case and its findings were analyzed. A 34-year-old Hispanic woman presented with an 8-year history of chronic recurrent posterior uveitis in both eyes secondary to VKH disease.
View Article and Find Full Text PDFMycophenolate Mofetil-Induced Pneumatosis Intestinalis.
Gastro Hep Adv
August 2024
Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
Chaperone-mediated autophagy (CMA) confers neuroprotection of HBO preconditioning against stroke.
Brain Res
January 2025
Department of Critical Care Medicine, Xijing Hospital, Fourth Military Medical University, 710032 Xi'an, Shaanxi, PR China; Department of Critical Care Medicine, Fourth People's Hospital, School of Medicine, Tongji University, Shanghai 200434, PR China; Shanghai Key Laboratory of Anesthesiology and Brain Functional Modulation, Clinical Research Center for Anesthesiology and Perioperative Medicine, Translational Research Institute of Brain and Brain-Like Intelligence, Fourth People's Hospital, School of Medicine, Tongji University, Shanghai 200434, PR China. Electronic address:
Previous attempts to identify neuroprotective targets for acute ischemic stroke by studying ischemic cascades and devising ways to suppress these pathways have failed in translational research. We hypothesized that studying the molecular determinants of endogenous neuroprotection, namely, the tolerance against ischemic stroke conferred by hyperbaric oxygen (HBO) preconditioning, via a well-established paradigm would reveal new neuroprotective targets. By a combination of proteomics, KEGG pathway analysis, lysosome fraction and western blot analysis, we found that chaperone-mediated autophagy (CMA) was activated by HBO preconditioning.
View Article and Find Full Text PDFA GC-MS-based untargeted metabolomics approach for comprehensive metabolic profiling of mycophenolate mofetil-induced toxicity in mice.
Front Mol Biosci
March 2024
Department of Hematology, Jining No.1 People's Hospital, Jining, China.
Article Synopsis
- Mycophenolate mofetil (MMF) is commonly used as an immunosuppressant in transplantation but can cause gastrointestinal toxicity, with limited understanding of its metabolic effects.
- In this study, mice were treated with MMF for two weeks, and a variety of metabolic changes were analyzed using gas chromatography-mass spectrometry and specific databases to understand the impacts on various organs.
- The results revealed that MMF treatment altered metabolite levels in several organs and disrupted amino acid and fatty acid metabolism, while also increasing certain immune cell types without significantly affecting others.
Microbial bile acid metabolite ameliorates mycophenolate mofetil-induced gastrointestinal toxicity through vitamin D3 receptor.
Am J Transplant
July 2024
Department of Urology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China; Institute of Urology, Capital Medical University, Beijing, China. Electronic address:
Article Synopsis
- Mycophenolate mofetil (MMF) is a common immunosuppressive drug used in organ transplants but causes gastrointestinal (GI) side effects that are not well understood.
- Research indicates that gut microbiota and their metabolites, particularly secondary bile acids (BAs), are significantly affected by MMF, which is linked to GI toxicity.
- The study highlights that supplementing with lithocholic acid can reduce MMF's negative effects on GI health, and the use of paricalcitol, a VDR agonist, may provide a potential treatment option for these side effects.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!